1
|
Henshaw SK: Unintended pregnancy in the
United States. Fam Plann Perspect. 30:24–29. 461998. View Article : Google Scholar : PubMed/NCBI
|
2
|
Finer LB and Henshaw SK: Abortion
incidence and services in the United States in 2000. Perspect Sex
Reprod Health. 35:6–15. 2003. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Piccinino LJ and Mosher WD: Trends in
contraceptive use in the United States: 1982–1995. Fam Plann
Perspect. 30:4–10. 461998. View
Article : Google Scholar
|
4
|
Gu Y, Liang X, Wu W, Liu M, Song S, Cheng
L, Bo L, Xiong C, Wang X, Liu X, et al: Multicenter contraceptive
efficacy trial of injectable testosterone undecanoate in Chinese
men. J Clin Endocrinol Metab. 94:1910–1915. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hay CJ, Brady BM, Zitzmann M, Osmanagaoglu
K, Pollanen P, Apter D, Wu FC, Anderson RA, Nieschlag E, Devroey P,
et al: A multicenter Phase IIb study of a novel combination on
intramuscular androgen (testosterone decanoate) and oral
progestogen (etonogestrel) for male hormonal contraception. J Clin
Endocrinol Metab. 90:2042–2049. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Frayne J, Taylor A, Cameron G and Hadfield
AT: Structure of insoluble rat sperm glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) via heterotetramer formation with Escherichia
coli GAPDH reveals target for contraceptive design. J Biol Chem.
284:22703–22712. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Aitken RJ, Baker MA, Doncel GF, Matzuk MM,
Mauck CK and Harper MJ: As the world grows: contraception in the
21st century. J Clin Invest. 118:1330–1343. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Picaud S, Da Costa D, Thanasopoulou A,
Filippakopoulos P, Fish PV, Philpott M, Fedorov O, Brennan P,
Bunnage ME, Owen DR, et al: PFI-1, a highly selective protein
interaction inhibitor, targeting BET Bromodomains. Cancer Res.
73:3336–3346. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Dey A, Nishiyama A, Karpova T, McNally J
and Ozato K: Brd4 marks select genes on mitotic chromatin and
directs postmitotic transcription. Mol Biol Cell. 20:4899–4909.
2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shang E, Nickerson HD, Wen D, Wang X and
Wolgemuth DJ: The first bromodomain of Brdt, a testis-specific
member of the BET sub-family of double-bromodomain-containing
proteins, is essential for male germ cell differentiation.
Development. 134:3507–3515. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Morinière J, Rousseaux S, Steuerwald U,
Soler-López M, Curtet S, Vitte AL, Govin J, Gaucher J, Sadoul K,
Hart DJ, et al: Cooperative binding of two acetylation marks on a
histone tail by a single bromodomain. Nature. 461:664–668. 2009.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Berkovits BD and Wolgemuth DJ: The role of
the double bromodomain-containing BET genes during mammalian
spermatogenesis. Curr Top Dev Biol. 102:293–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Filippakopoulos P, Qi J, Picaud S, Shen Y,
Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et
al: Selective inhibition of BET bromodomains. Nature.
468:1067–1073. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dawson MA, Prinjha RK, Dittmann A,
Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C,
Savitski MM, et al: Inhibition of BET recruitment to chromatin as
an effective treatment for MLL-fusion leukaemia. Nature.
478:529–533. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fish PV, Filippakopoulos P, Bish G,
Brennan PE, Bunnage ME, Cook AS, Federov O, Gerstenberger BS, Jones
H, Knapp S, et al: Identification of a chemical probe for bromo and
extra C-terminal bromodomain inhibition through optimization of a
fragment-derived hit. J Med Chem. 55:9831–9837. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang H, Xiang ML, Liang JY, Zeng T, Zhang
XN, Zhang J and Yang SY: Combination of pharmacophore model,and
molecular docking to identify novel inhibitors of S6K1. Mol Divers.
17:767–772. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ren JX, Li LL, Zheng RL, Xie HZ, Cao ZX,
Feng S, Pan YL, Chen X, Wei YQ and Yang SY: Discovery of novel
Pim-1 kinase inhibitors by hierarchical multistage virtual
screening approach based on SVM model,pharmacophore, and molecular
docking. J Chem Inf Model. 51:1364–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Matzuk MM, McKeown MR, Filippakopoulos P,
Li Q, Ma L, Agno JE, Lemieux ME, Picaud S, Yu RN, Qi J, et al:
Small-molecule inhibition of BRDT for male contraception. Cell.
150:673–684. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Leach AR, Gillet VJ, Lewis RA and Taylor
R: Three-dimensional pharmacophore methods in drug discovery. J Med
Chem. 53:539–558. 2010. View Article : Google Scholar
|
20
|
Steindl T and Langer T: Influenza virus
neuraminidase inhibitors: generation and comparison of
structure-based and common feature pharmacophore hypotheses and
their application in virtual screening. J Chem Inf Comput Sci.
44:1849–1856. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Smellie A, Stanton R, Henne R and Teig S:
Conformational analysis by intersection: CONAN. J Comput Chem.
24:10–20. 2003. View Article : Google Scholar
|
22
|
Yang SY: Pharmacophore modeling and
applications in drug discovery: challenges and recent advances.
Drug Discov Today. 15:444–450. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Jones G, Willett P, Glen RC, Leach AR and
Taylor R: Development and validation of a genetic algorithm for
flexible docking. J Mol Biol. 267:727–748. 1997. View Article : Google Scholar : PubMed/NCBI
|
24
|
Dhalluin C, Carlson JE, Zeng L, He C,
Aggarwal AK and Zhou MM: Structure and ligand of a histone
acetyltransferase bromodomain. Nature. 399:491–496. 1999.
View Article : Google Scholar : PubMed/NCBI
|